Myopia – Strategies for optometry-led prevention and control of myopia - 1 interactive CET point
Sunday, March 31, 2019 12:00 - 13:00
The prevalence of myopia is escalating at an alarming rate, not only in Asia, but across the globe. This trend is set to continue, with 5 billion people expected to be affected worldwide by 2050. More worryingly, these prevalence rises appear to coincide with a myopic shift, whereby the degree of myopia in the population has been observed to have increased. Myopia control is now an urgent public health priority given the escalating risk of potentially blinding ocular pathology associated with myopia including cataract, glaucoma, retinal detachment and myopic maculopathy. Eye health professionals urgently need to reconsider their attitudes and clinical practice in relation to myopia which is no longer an optical convenience, but a modifiable risk factor for blinding disease. This interactive presentation will explore the most important impacts of myopia control. The various methods currently available will be presented with specific focus on their application in routine clinical practice. Various approaches to the integration of myopia control into primary care practice will be covered, including discussion of the supporting research available to inform the required evidence-based evolution of clinical practice for myopia.
Understand the trends in myopia development and the risks associated with the increasing prevalence of myopia, so you can explain the implications of myopia to patients and parents
Recognise the effect of environmental influences on myopia onset and progression, in order to appropriately inform and advise patients on their lifestyle choices
Identify evidence-based myopia management options and recognise how to incorporate myopia control strategies into your clinical practice today
Recognise the supports available to further update practitioner knowledge and skills in order to effectively manage myopia
Saoirse McCrann is an Optometrist and PhD researcher at the Centre for Eye Research in Technological University Dublin. Saoirse’s passion is to tackle the current myopia crisis, and thus carried out PhD research focusing on finding new ways and means to limit the progression of myopia in children. Saoirse has carried out the first study in the world to investigate an association between mobile phone use and shortsightedness, and has also published research exploring parental attitudes toward myopia and awareness of the condition.
Saoirse is a clinical trial investigator on the MOSAIC clinical trial and, along Prof. James Loughman and Mr Ian Flitcroft, is investigating the potential of 0.01% unpreserved atropine in slowing the progression of myopia in children. This exciting, novel clinical trial is a primary focus of Saoirse’s research in pioneering advances for the control and prevention of myopia in children.